With over 900,000 U.S. patients undergoing bone-related surgeries each year, a New-York-based startup called EpiBone wants to simplify how we construct new bone. Its technology, while still being tested, is a revolutionary procedure that utilizes a patients’ own stem cells to engineer a personalized bone graft, giving surgeons simplified procedures and patients highly accurate bone formation and regeneration without the complication of synthetic implants.
Samumed’s Osteoarthritis and Tendinopathy Research Selected for Multiple Presentations at the 2018 Osteoarthritis Research Society Int’l World Congress
April 23, 2018
Alphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics Products
November 5, 2009